Full-Time

Science Prospects

Posted on 4/10/2025

Aetion

Aetion

51-200 employees

Real-world evidence software for life sciences

Compensation Overview

$65k - $175k/yr

New York, NY, USA

In Person

Category
Medical, Clinical & Veterinary (2)
,
Requirements
  • Graduate degree (in epidemiology, biostatistics, health economics or a related field).
  • 1+ year of related analytical experience (MSc, MPH) or a PhD with related analytical experience with research methods for epidemiological studies (i.e. prospective cohort study, case control study, confounding control, propensity score methods, multivariate regression).
  • Experience engaging with customers (in-person, on the phone and in writing) or demonstrated experience in external facing roles.
  • Working knowledge of health care datasets including medical and pharmacy claims, EMR/EHR, genomics, registry data or demonstrated experience and facility with other health care data sets.
Responsibilities
  • Work with client scientists to guide them in designing, creating and delivering scientific through the Substantiate application.
  • Work with Aetion teammates to create and implement detailed protocols for scientific use cases and scientific validation studies.
  • Develop a deep understanding of the Substantiate application and measurement system, and share that understanding with customers and teammates through 1:1 discussion, written communications and/or demonstrations.
  • Develop and maintain scientific assets, such as study templates, outcomes, and measures in the Aetion Measure Library (an extensive library of measurements addressing key clinical conditions) and other deployable scientific components.
  • Develop and maintain knowledge base articles, documentation, and other learning materials, in text and video form.
  • Respond to and follow-up on customer requests submitted through the Aetion support system.
Desired Qualifications
  • Experience with cross-functional teams is a plus.
  • Ability to travel occasionally to other Aetion offices or to client sites.
  • Outstanding attention to detail and organizational skills.
  • Strong ability for critical thinking.
  • Strong ability to quickly learn new tools.
  • Strong ability to self-motivate and manage conflicting priorities in a fast-paced environment.
  • Excellent communication in verbal and written form.
  • Eager to “get things right.”
  • Strong proficiency in written and verbal English communication is essential.

Aetion builds software that helps life sciences companies, regulators, and purchasers analyze real-world data to understand how medical interventions perform in real patient care. Its platform and apps manage longitudinal health data and can generate synthetic data using AI, enabling hypothesis testing, analysis, and ongoing safety monitoring, with additional data science and regulatory services. The solution emphasizes end-to-end real-world data workflows and rapid, ROI-focused insights that streamline decision-making. The goal is to maximize value from real-world data and speed informed decisions to improve patient care.

Company Size

51-200

Company Stage

Series C

Total Funding

$203.6M

Headquarters

New York City, New York

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Datavant acquisition completed July 2025 creates end-to-end RWE platform, doubling life sciences team and expanding addressable market.[1]
  • AWS Marketplace integration March 2025 removes procurement barriers and enables scalable cloud-based evidence generation for global customers.[2]
  • Barcelona technology hub doubled engineering capacity, developing Aetion Discover for visual-first exploratory analysis workflows.[3]

What critics are saying

  • Datavant integration erodes Aetion's standalone brand, driving client attrition to competitors like IQVIA within 6-12 months.[6]
  • FDA regulatory rejection of synthetic health data blocks life sciences revenue, forcing clients to compliant alternatives.[6]
  • Barcelona hub attrition after rapid scaling enables Komodo Health to outpace Aetion in rapid-cycle analytics capabilities.[6]

What makes Aetion unique

  • Aetion's rapid-cycle analytics technology uniquely transforms real-world clinical and financial data into regulatory-grade evidence quickly.[1][5]
  • Combined Datavant-Aetion ecosystem spans 300+ data partners across EHRs, claims, pharmacy, registries, and social determinants.[1]
  • Aetion's AI-driven platform automates hypothesis generation and analysis, accelerating insights from complex longitudinal datasets.[6]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision insurance

Free membership to OneMedical

FSA

4% 401(k) match

Commuter benefits for parking & transit

Unlimited PTO

Paid parental leave

Wellness stipend

Company activities

Growth & Insights and Company News

Headcount

6 month growth

8%

1 year growth

13%

2 year growth

10%
Business Wire
May 16th, 2025
Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data

Datavant, a leading health data platform company, today announced that it has signed an agreement to acquire Aetion, a leading real-world evidence (RWE) plat...

Endpoints News
May 15th, 2025
Exclusive: Datavant to acquire real-world data specialist Aetion, doubling life sciences team

Exclusive: Datavant to acquire real-world data specialist Aetion, doubling life sciences team.

Endpoints News
May 15th, 2025
Datavant Acquires Aetion, Expands Team

Datavant is acquiring Aetion, a competitor in the real-world data sector, as reported exclusively by Endpoints News. This acquisition will lead to Datavant doubling its life sciences team. Further details are expected to be announced by Datavant on Thursday.

PR Newswire
Mar 31st, 2025
Aetion Launches Aetion® Evidence Platform Availability In Aws Marketplace, Accelerating Real-World Evidence Benefits For Its Customers

Aetion's industry-leading platform integrates advanced analytics, scalable workflows and actionable insights empowering organizations to unlock the full potential of their data and achieve measurable impactNEW YORK, March 31, 2025 /PRNewswire/ -- Aetion , the global leader in real-world evidence (RWE) technology and analytics, today announced the availability of its Aetion® Evidence Platform (AEP) in Amazon Web Services (AWS) Marketplace, a digital catalog with thousands of software listings from independent software vendors that make it easy to find, test, buy, and deploy software that runs on AWS. This launch removes implementation barriers, simplifies procurement and enables life sciences organizations, payers and regulators to harness scalable, cloud-based evidence generation with the security and reliability of AWS.AEP empowers organizations to analyze real-world data (RWD) to generate transparent, reproducible and regulatory-grade evidence for decision-making in drug development, market access, policy and pricing. By leveraging AWS Marketplace, Aetion streamlines access to its platform and reliable, fit-for-purpose solutions tailored to meet each organization's specific objectives, as well as accelerating time-to-insights and ensuring compliance with global regulatory standards.Aetion relies on AWS as its core infrastructure, leveraging services such as Amazon Bedrock to power its artificial intelligence and machine learning (AI/ML)-driven capabilities in order to unlock hidden insights about patient populations and translate scientific intent to results. These technologies enhance AEP's ability to process complex RWD at scale, enabling sophisticated hypothesis generation and analysis automation for evidence generation."The availability of AEP in AWS Marketplace underscores our commitment to providing scalable, high-impact solutions that help organizations make real-world data work for them," said Jay Podence, senior vice president of Commercial Partnerships at Aetion. "By integrating with AWS, we offer our new and existing customers a seamless path to deploy and scale real-world evidence studies with enhanced efficiency and security. This is the first step in our vision to expand our collaboration with AWS to bring more value to our customers

株式会社PR TIMES
Feb 19th, 2025
NEC invests in Aetion for RWD/RWE collaboration

NEC's CVC fund, NEC Orchestrating Future Fund, has invested in Aetion, Inc., a U.S. company providing a medical data analysis platform. This investment aims to enhance collaboration in utilizing real-world data (RWD) and real-world evidence (RWE) for drug development. Aetion's platform, Aetion Evidence Platform, is used globally by pharmaceutical companies and healthcare organizations to improve decision-making. NEC and Aetion will explore synergies to streamline drug development processes.

INACTIVE